Sanofi (SNY) Change in Account Payables (2013 - 2021)

Sanofi (SNY) has 4 years of Change in Account Payables data on file, last reported at $101.7 million in Q4 2021.

• Quarterly Change in Account Payables rose 616.78% year-over-year to $101.7 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $275.3 million (changed N/A YoY) and the FY2025 annual result came in at $463.3 million, down 45.05% from the prior year.
• Change in Account Payables advanced to $101.7 million in Q4 2021 per SNY's latest filing, from $14.2 million in the prior quarter.
• The five-year high for Change in Account Payables was $101.7 million in Q4 2021, with the low at -$1.2 million in Q4 2019.
• Average Change in Account Payables over 3 years is $38.2 million, with a median of $14.2 million recorded in 2020.
• Year-over-year, Change in Account Payables soared 1265.29% in 2020 and soared 616.78% in 2021.
• Sanofi's Change in Account Payables stood at -$1.2 million in 2019, then soared by 1265.29% to $14.2 million in 2020, then soared by 616.78% to $101.7 million in 2021.
• Business Quant data shows SNY's Change in Account Payables at $101.7 million in Q4 2021, $14.2 million in Q4 2020, and -$1.2 million in Q4 2019.